Moxetumomab pasudotox as re-treatment for heavily-pretreated relapsed hairy cell leukemia.

Autor: Yurkiewicz, Ilana R.1 (AUTHOR), Coutre, Steve1 (AUTHOR), Ghesquieres, Herve2 (AUTHOR), Pastan, Ira3 (AUTHOR), Kreitman, Robert J.3 (AUTHOR)
Zdroj: Leukemia & Lymphoma. Nov 2021, Vol. 62 Issue 11, p2812-2814. 3p.
Databáze: Academic Search Ultimate